M&A Deal Summary |
|
|---|---|
| Date | 2006-04-21 |
| Target | Guidant |
| Sector | Life Science |
| Buyer(s) | Boston Scientific |
| Deal Type | Add-on Acquisition |
| Deal Value | 24.6B USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1979 |
| Sector | Medical Products |
| Employees | 48,000 |
| Revenue | 16.7B USD (2024) |
Boston Scientific is a medical technology company that offers products and technologies used to diagnose and treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. Boston Scientific was founded in 1979 and is based in Marlborough, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 10 of 70 |
| Sector: Life Science M&A | 2 of 7 |
| Type: Add-on Acquisition M&A Deals | 10 of 54 |
| State: Indiana M&A | 1 of 1 |
| Country: United States M&A | 9 of 55 |
| Year: 2006 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 36 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2005-04-18 |
TriVascular
Santa Rosa, California, United States TriVascular, Inc. is a medical device company that design and manufacture endovascular aortic repair (EVAR). TriVascular’s initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-01-05 |
EndoTex Interventional Systems
Cupertino, California, United States EndoTex Interventional Systems, Inc. is a medical device company provides carotid artery stent. |
Buy | - |